Effect of Curcumin on Osteoprosis in patient with Spinal Cord Injury

Phase 3

• Conditions: spinal cord injury.; Injury of spinal cord, level unspecified

• Registration Number: IRCT2016010225805N1
• Lead Sponsor: Vice Chancellor for research of Ilam University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

age equal to 18 years; trauma; recent SCI (less than 6 months); paraplegia or quadriplegia move engagement protocol spinal cord injury America Association (ASIA).

Exclusion criteria: any secondary cause of osteoporosis such as metabolic or endocrine disease; osteogenesis imperfecta; tumors; chronic cardiovascular diseases; liver; anti-osteoporosis medications during the selection of patients; Alcoholism; pregnancy; chronic use of steroids; smoking; older than 70

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bone Density of Total Hip. Timepoint: Before intervention and 6 month after intervetion. Method of measurement: Dansitometry Lab.;Bone Density of lumbar vertebral (L1-L4). Timepoint: Before intervention and 6 month after intervetion. Method of measurement: Laboratory assay.;Bone Density of Femoral Neck. Timepoint: Before intervention and 6 month after intervetion. Method of measurement: Laboratory assay.;Bone Specific alkaline phsphatase. Timepoint: Before intervention , 3 month after intervention and 6 month after intervetion. Method of measurement: ElISA.;Propeptide amino-terminal of type I procollagen. Timepoint: Before intervention and 6 month after intervetion. Method of measurement: ElISA.;Osteoclacin. Timepoint: Before intervention and 6 month after intervetion. Method of measurement: ElISA.